vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $44.5M, roughly 1.1× Cronos Group Inc.). Cronos Group Inc. runs the higher net margin — -4.1% vs -5.1%, a 1.0% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs -14.2%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $4.1M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 5.6%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
CRON vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $50.3M |
| Net Profit | $-1.8M | $-2.6M |
| Gross Margin | 36.4% | — |
| Operating Margin | -16.8% | -1.9% |
| Net Margin | -4.1% | -5.1% |
| Revenue YoY | 47.0% | -14.2% |
| Net Profit YoY | -104.2% | -14.5% |
| EPS (diluted) | $-0.01 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $50.3M | ||
| Q3 25 | $36.3M | $52.2M | ||
| Q2 25 | $33.5M | $60.4M | ||
| Q1 25 | $32.3M | $40.2M | ||
| Q4 24 | $30.3M | $58.6M | ||
| Q3 24 | $34.3M | $60.1M | ||
| Q2 24 | $27.8M | $46.8M | ||
| Q1 24 | $25.3M | $45.1M |
| Q4 25 | $-1.8M | $-2.6M | ||
| Q3 25 | $26.0M | $-4.2M | ||
| Q2 25 | $-39.7M | $-2.7M | ||
| Q1 25 | $6.1M | $-4.8M | ||
| Q4 24 | $43.7M | $-2.2M | ||
| Q3 24 | $8.3M | $-7.0M | ||
| Q2 24 | $-8.8M | $-12.8M | ||
| Q1 24 | $-2.2M | $-13.2M |
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
| Q4 25 | -16.8% | -1.9% | ||
| Q3 25 | -1.4% | -0.6% | ||
| Q2 25 | -15.9% | 4.8% | ||
| Q1 25 | -12.6% | -17.2% | ||
| Q4 24 | -37.5% | 2.6% | ||
| Q3 24 | -98.2% | -0.6% | ||
| Q2 24 | -56.1% | -16.4% | ||
| Q1 24 | -63.1% | -16.7% |
| Q4 25 | -4.1% | -5.1% | ||
| Q3 25 | 71.4% | -8.0% | ||
| Q2 25 | -118.7% | -4.4% | ||
| Q1 25 | 19.0% | -11.8% | ||
| Q4 24 | 144.3% | -3.8% | ||
| Q3 24 | 24.4% | -11.7% | ||
| Q2 24 | -31.5% | -27.4% | ||
| Q1 24 | -8.9% | -29.4% |
| Q4 25 | $-0.01 | $-0.11 | ||
| Q3 25 | $0.07 | $-0.18 | ||
| Q2 25 | $-0.10 | $-0.12 | ||
| Q1 25 | $0.02 | $-0.21 | ||
| Q4 24 | $0.12 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.31 | ||
| Q2 24 | $-0.02 | $-0.57 | ||
| Q1 24 | $-0.01 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $1.1B | $-18.2M |
| Total Assets | $1.2B | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $10.5M | ||
| Q3 25 | $824.2M | $8.1M | ||
| Q2 25 | $834.4M | $9.1M | ||
| Q1 25 | $837.8M | $5.9M | ||
| Q4 24 | $858.8M | $12.4M | ||
| Q3 24 | $862.0M | $10.1M | ||
| Q2 24 | $848.2M | $9.3M | ||
| Q1 24 | $855.1M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.1B | $-18.2M | ||
| Q3 25 | $1.1B | $-12.1M | ||
| Q2 25 | $1.1B | $-7.7M | ||
| Q1 25 | $1.1B | $-8.1M | ||
| Q4 24 | $1.1B | $-4.4M | ||
| Q3 24 | $1.1B | $1.6M | ||
| Q2 24 | $1.1B | $6.5M | ||
| Q1 24 | $1.1B | $18.0M |
| Q4 25 | $1.2B | $434.9M | ||
| Q3 25 | $1.2B | $435.2M | ||
| Q2 25 | $1.2B | $438.1M | ||
| Q1 25 | $1.2B | $441.0M | ||
| Q4 24 | $1.2B | $471.0M | ||
| Q3 24 | $1.2B | $495.7M | ||
| Q2 24 | $1.1B | $494.9M | ||
| Q1 24 | $1.1B | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $4.3M |
| Free Cash FlowOCF − Capex | $9.7M | $4.1M |
| FCF MarginFCF / Revenue | 21.8% | 8.2% |
| Capex IntensityCapex / Revenue | 4.8% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $4.3M | ||
| Q3 25 | $13.3M | $295.0K | ||
| Q2 25 | $2.8M | $1.6M | ||
| Q1 25 | $-2.1M | $-7.7M | ||
| Q4 24 | $7.7M | $8.0M | ||
| Q3 24 | $11.6M | $1.3M | ||
| Q2 24 | $1.7M | $-10.4M | ||
| Q1 24 | $-2.2M | $-2.8M |
| Q4 25 | $9.7M | $4.1M | ||
| Q3 25 | $8.8M | $-246.0K | ||
| Q2 25 | $-1.0M | $1.2M | ||
| Q1 25 | $-17.4M | $-8.0M | ||
| Q4 24 | $4.2M | $7.0M | ||
| Q3 24 | $5.2M | $-1.1M | ||
| Q2 24 | $1.0M | $-10.6M | ||
| Q1 24 | $-3.9M | $-4.7M |
| Q4 25 | 21.8% | 8.2% | ||
| Q3 25 | 24.3% | -0.5% | ||
| Q2 25 | -3.0% | 1.9% | ||
| Q1 25 | -53.8% | -19.8% | ||
| Q4 24 | 13.8% | 12.0% | ||
| Q3 24 | 15.1% | -1.8% | ||
| Q2 24 | 3.7% | -22.7% | ||
| Q1 24 | -15.5% | -10.4% |
| Q4 25 | 4.8% | 0.3% | ||
| Q3 25 | 12.3% | 1.0% | ||
| Q2 25 | 11.5% | 0.6% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 1.7% | ||
| Q3 24 | 18.7% | 4.0% | ||
| Q2 24 | 2.6% | 0.5% | ||
| Q1 24 | 6.8% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
